Funding round led by Shanghai Healthcare Capital. The financing round will enable Biomica to forge ahead, developing its pipeline of microbiome-based therapeutics.
The findings of a new research suggest that dietary and antibacterial strategies may help to prevent neutropenia-related fever after cancer therapy.
The findings of a new research suggest that obesity-induced changes in the vaginal microbiota can affect the immune responses against viral infection.
The findings of a new research support the link between gut microbes and depression, and suggest that the gut microbiota can be a target for future therapies.
Biopharma companies are currently developing Live Biotherapeutic Products. We discussed this topic with Morten Isaksen (BIO-ME).
Strategic investment in dynamic research field of skin microbiome to drive future of skin care.
The findings of a japanese research suggest that several viruses are linked to specific populations and diseases.
Researchers have found that a diet low in fermentable carbohydrates can alter the human microbiota in ways that influence the expression of genes involved in inflammation and intestinal integrity.
Emily Hollister discussed how Diversigen demonstrates the rapidity of microbial gene expression changes potentially impacting host-microbiome interactions.
With the achievement of this new milestone, both companies will now advance this research which focuses on developing innovative therapies for metabolic diseases.
